Abstract
As experience with all trans-retinoic acid (ATRA) in acute promyelocytic leukemia (APL) has grown, its’ toxicity profile became more extensive. We initially present a case of APL in which hypercalcemia and Diffuse Alveolar Hemorrhage occurred simultaneously after introduction of ATRA, followed by a systematic review of the literature. A comity of 5 specialists analyzed and discussed each reported case on the basis of the CAse REport (CARE) guidelines. Level III guides were suggested for diagnosis and treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
